Home
/
NowPatient Blog
/
Is Kiwifruit Better Than MiraLAX for Chronic Constipation?

Is Kiwifruit Better Than MiraLAX for Chronic Constipation?

Navin Khosla NowPatientGreen tick
Created on 27 Aug 2024
Updated on 7 Oct 2024

Chronic constipation is a widespread issue affecting millions worldwide, causing discomfort, reduced quality of life, and increased healthcare costs. Conventional treatments like laxatives may provide temporary relief by helping to ease the flow of materials through the intestines but many patients with chronic constipation seek more natural, long-term solutions. In this guide, the efficacy of kiwifruit, prunes, and psyllium (MiraLAX) as potential remedies for chronic constipation has gained significant research interest.

Prevalence and impact of chronic constipation

Chronic constipation is a common gastrointestinal disorder that affects up to 16% of adults in the United States. The latest Dietary Guidelines for Americans, 2020–2025, states that over 90% of women and 97% of men do not meet the recommended daily intakes for dietary fibre. This condition can significantly impact an individual’s quality of life, leading to discomfort and embarrassment. The associated healthcare costs are substantial, with studies estimating the economic burden of irritable bowel syndrome with constipation (IBS-C) alone to be in the billions of dollars annually.

Conventional treatments

Conventional treatments to relieve constipation often include over-the-counter laxatives, such as MiraLAX (psyllium), Milk of Magnesia (contains magnesium), senna or prescription medications. While these drugs can provide temporary relief, they are not without their drawbacks. Laxatives may cause undesirable side effects like cramping, bloating, and diarrhoea, and their long-term efficacy is often limited, with studies showing they help fewer than half of patients and offer only a 7-15% improvement over placebo.

Natural alternatives

In recent years, researchers have explored the potential of natural, dietary-based interventions to address chronic constipation. Among the promising alternatives, three have gained significant attention: kiwifruit, prunes, and psyllium (MiraLAX).

Kiwifruit

Kiwifruit, particularly the green Hayward variety and the golden SunGold cultivar have been the subject of several clinical studies investigating their effects on constipation. These nutrient-dense fruits are rich in dietary fibre, enzymes like actinidin, and other compounds that may contribute to improved bowel function.

Prunes

Dried prunes have long been recognised as a natural remedy for constipation. Prunes are high in fibre, sorbitol (a natural laxative), and other beneficial compounds that can help regulate bowel movements.

Psyllium (MiraLAX)

Psyllium, the main ingredient in the over-the-counter laxative MiraLAX, is a soluble fibre derived from the husks of the Plantago ovata plant. Psyllium has been extensively studied for its effectiveness in treating chronic constipation by adding bulk to stool and improving bowel function.

How do kiwi fruit, prunes and MiraLAX compare?

To better understand the relative efficacy of these natural treatments, a recent clinical trial conducted by the Department of Gastroenterology University of Michigan compared the effects of kiwifruit, prunes, and psyllium (MiraLAX) in a group of 79 adults with chronic constipation.

Study design

The study was randomised, and partially blind in design and participants were assigned to one of three treatment groups:

  • 2 whole green kiwifruits per day
  • 50 grams of prunes (about 6 prunes) twice daily
  • 6 grams of psyllium (MiraLAX) twice daily

Participants were instructed to avoid any other high-fibre foods or supplements containing the study interventions during the 4-week treatment period.

What did the study measure?

The main measure was the proportion of participants in each group who reported an increase of 1 or more complete spontaneous bowel movements (CSBMs) per week, compared to the 2-week baseline period.

Results

The results of the study showed that all three treatments were effective in increasing the number of weekly CSBMs:

  • 45% of kiwifruit participants reported an increase of 1 or more CSBMs
  • 67% of prune participants reported an increase of 1 or more CSBMs
  • 64% of psyllium (MiraLAX) participants reported an increase of 1 or more CSBMs

While the prune and psyllium groups had slightly higher response rates, the differences were not statistically significant, indicating that all three treatments were equally effective in improving bowel function.

Other results

The study also measured several other things:

Stool consistency and straining

Both the kiwifruit and prune groups experienced significant improvements in stool consistency, as measured by the Bristol Stool Form Scale. Additionally, participants in the kiwifruit group reported a significant reduction in straining during bowel movements.

Side effects

When it came to tolerability, kiwifruit stood out as the most well-tolerated treatment. Only 11% of kiwifruit participants reported bloating, and none reported gas or abdominal pain. In contrast, the prune and psyllium groups experienced higher rates of side effects, such as bloating, gas, and abdominal pain.

This comparative study offers several important insights for healthcare providers and patients dealing with chronic constipation:

  • Efficacy of natural treatments: The study confirms that all three treatments; kiwifruit, prunes, and psyllium (MiraLAX) can be effective in relieving the symptoms of chronic constipation, providing a good alternative to conventional laxatives
  • Tolerability and satisfaction: Kiwifruit appears to be the most well-tolerated and preferred option among the three, with lower rates of side effects
  • Personalised approach: Given the individual variability in response to the treatments healthcare providers should consider a personalised approach, taking into account patient preferences, tolerance, and specific symptoms when recommending natural treatments for chronic constipation

Limitations and future research

While this study provides valuable insights, it is not without its limitations. The number of participants may have been too small to detect statistically significant differences between the treatments on some of the measures. Additionally, the study was not fully blinded, as participants were aware of the assigned treatment.

Moving forward, larger, fully randomized, and double-blinded trials could help further confirm the comparative efficacy and long-term effects of kiwifruit, prunes, and psyllium (MiraLAX) in the management of chronic constipation. Exploring the combined effects of these natural treatments or investigating their impact on the gut microbiome could also be useful for future research.

Conclusion

Kiwifruit, prunes, and psyllium (MiraLAX) all have a role to play in the treatment of constipation. While the three treatments have shown similar efficacy in improving bowel function, kiwifruit stood out as the most well-tolerated and preferred option among study participants. As healthcare providers seek to personalise treatment plans for their patients, this research provides valuable insights to guide the integration of natural, dietary-based therapies alongside conventional approaches in the management of chronic constipation.

Sources

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Now Patient Data Security

Data Security

Our Commitment to You.

Learn moreNow Patient Data SecurityNow Patient Data Security

WHY WE BUILT NOWPATIENT

We are committed to helping everyone, everywhere live healthier lives

The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

NowPatient dashboard

Your Questions Answered

For your peace of mind, we can answer your questions quickly

What does NowPatient do?

NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.

Get started today and benefit from medication remindersGet Treated PrivatelyNHS online pharmacyGP appointment bookingRx savings cardDrug CouponsUS drug savings programshealth conditions informationgenetic testinghome test kitsBMI RisksType 2 Diabetes Riskspollen meterair quality monitor, and lots more!

Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.

UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.

US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.

Where is NowPatient located?

NowPatient has offices in the United Kingdom and United States.

In the UK, we are located at:

NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA

In the US, we are located at:

NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX

How can I contact NowPatient?

To contact NowPatient, please use the contact form available on the Contact Us page.

Alternatively, if you need to speak to us, you can reach us on the following numbers:

UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977

Who owns NowPatient?

NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.

Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).

Can you tell me more about your NHS online pharmacy?

NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.

Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).

Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.

How do I make a complaint?

From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.

Can you tell me more about NowPatient’s prescribing services for treatments offered?

Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:

• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old

NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.

Can you tell me more about NowPatient’s US services?

Our head of US services is Dr. Jamie Winn.

You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.

We do not provide any prescribing services or dispensing services in the United States.

Is NowPatient legit and can I trust information from NowPatient?

Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.

NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.

Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:

NowPatient Trustpilot

What are NowPatient’s opening hours?

Our office hours are:

UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST

Please note that we are closed at weekends.

In the event of a medical life-threatening emergency please call:

UK – 999
US – 911

In the event of a medical emergency which is not life-threatening please call:

UK – 111

Find more answers